LEVODOP PRODRUGS, BASED ON THEM COMPOSITIONS AND THEIR APPLICATION Russian patent published in 2009 - IPC C07C229/36 C07C235/60 C07D213/79 A61K31/216 A61K31/215 A61K31/24 A61K31/4409 A61K31/455 A61P25/16 

Abstract RU 2365580 C2

FIELD: chemistry.

SUBSTANCE: invention relates to levodop prodrugs, their stereoisomers, enantiomers or pharmaceutically acceptable salts and based on them pharmaceutical composition for ensuring slowed levodop release, as well as to versions of their application and methods of obtaining them, compounds can be applied for treatment or prevention of diseases in which levodop application is indicated. In general formula (I): , Q is selected from X-CO-; X is selected from -O- and -NH-; n equals integer number from 2 to 4; each R1 and R2 is independently selected from hydrogen, -OH, C1-4alkyl and substituted C1-4alkyl, where substituting group is -OH; R3 and R4 represent hydrogen; R5 is selected from hydrogen, C1-4alkyl, phenyl, substituted phenyl, where each substituting group is independently selected from C1-6alcoxy, C1-6alkyl, halogen and -OH; C3-8cycloalkyl, pyridyl, substituted pyridyl, where each substituting group is independently selected from C1-6alkyl and C1-6alcoxy; on condition that formula (I) compound is not a derivative of 1,3-dihexadecanoylpropane-1,2,3-triol.

EFFECT: elaboration of pharmaceutical composition for ensuring slowed levodop release.

48 cl, 4 dwg, 32 ex

Similar patents RU2365580C2

Title Year Author Number
LEVODOPA MESYLATE PRODRUG, COMPOSITION THEREOF AND USE 2006
  • Sjan Tszja-Nin
  • Daj Sjuehdun
  • Chzhou Sindi S.
  • Li Tszjan'Khua
  • Ngujen Mark K.
RU2429223C2
PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF LEVODOPA PRODRUG AND METHODS OF USING 2010
  • Mao Chen
  • Pargaonkar Nikkhil
  • Morer Laura E.
  • Ma Sarina Grehjs Kharris
RU2537137C2
PRODRUG OF THE AMINO ACID DERIVATIVE 2017
  • Otake, Norikazu
  • Hashihayata, Takashi
  • Matsuda, Yohei
  • Masuda, Seiji
  • Yamauchi, Yuko
RU2739318C2
SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS 2011
  • Olkhava Edvard Dzhejms
  • Chesuort Richard
  • Kuntts Kevin Uejn
  • Richon Viktoriya Mari
  • Pollok Roj Makfarlejn
  • Dejgl Skott Richard
RU2606514C2
CONDENSED QUINOLINE DERIVATIVE AND USE THEREOF 2005
  • Kadzino Masakhiro
  • Kherd Nikolas Uill'Jam
  • Tarui Naoki
  • Banno Khirosi
  • Kavano Jasukhiko
  • Inatomi Nobukhiro
RU2384571C2
NONSTEROIDAL MODULATORS OF GLUCOCORTICOID RECEPTORS FOR LOCAL DRUG DELIVERY 2016
  • Johnson, Patrick Stephen
  • Dack, Kevin Neil
  • Henriksson, Krister
RU2731618C2
COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS 2016
  • Wenglowsky Steven Mark
  • Brooijmans Natasja
  • Miduturu Chandrasekhar V.
  • Bifulco Neil
RU2744974C2
FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS 2014
  • Bifalko Nil
  • Dipetro Lusian V.
  • Khodaus Brajan L.
  • Miduturu Chandrasekkhar V.
RU2704112C2
PPAR-SUPPORTING COMPOUNDS FOR TREATING METABOLIC DISEASES 2014
  • Tanis Steven P.
  • Larsen Scott D.
  • Artman Gerald D. Iii
  • Parker Timothy
RU2687490C2
PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE AND ITS PHARMACEUTICALLY ACCEPTABLE SALT 2017
  • Mizuno, Tsuesi
  • Simada, Tomokhiro
  • Unoki, Gen
  • Maruyama, Akinobu
  • Sasaki, Kosuke
  • Ekosaka, Takuya
  • Takakhasi, Khirosi
  • Khorie, Kekhei
  • Sakai, Yuri
RU2796400C2

RU 2 365 580 C2

Authors

Sjan Tszja-Nin

Gellop Mark A.

Chzhou Sindi S.

Ngujen Mark

Daj Sjuehdun

Li Tszjan'Khua

Kandi Kennet K.

Dzhambe Nel'Son L.

Dates

2009-08-27Published

2005-06-03Filed